Experimental drug helps celiac patients tolerate gluten

06/5/2009 | WJBF-TV (Augusta, Ga.)

Researchers are hopeful an experimental drug called AT-1001 could be a new treatment for celiac disease, which now is managed only by a gluten-free diet. The drug works by inhibiting a protein that regulates the absorption of nutrients, essentially keeping gluten out of the small intestine. So far, patients who have taken the drug seem to be able to tolerate foods containing gluten with few or no side effects.

View Full Article in:

WJBF-TV (Augusta, Ga.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX